|
1
|
Milenković V, Lazović B, Mačvanski M,
Jeremić K and Hrgović Z: Clinical outcome of a FIGO sage IV
gestational choriocarcinoma. Case Rep Oncol. 6:504–507. 2013.
View Article : Google Scholar
|
|
2
|
Bafico A, Liu G, Yaniv A, Gazit A and
Aaronson SA: Novel mechanism of Wnt signalling inhibition mediated
by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol.
3:683–686. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ogoshi K, Kasamatsu A, Iyoda M, Sakuma K,
Yamatoji M, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dickkopf-1 in human oral cancer. Int J Oncol. 39:329–336.
2011.PubMed/NCBI
|
|
4
|
Gao C, Xie R, Ren C and Yang X: Dickkopf-1
expression is a novel prognostic marker for gastric cancer. J
Biomed Biotechnol. 2012:8045922012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li S, Qin X, Guo X, Cui A, He Y, Wei S,
Wang X and Shan B: Dickkopf-1 is oncogenic and involved in invasive
growth in non small cell lung cancer. PLoS One. 8:e849442013.
View Article : Google Scholar
|
|
6
|
Kyvernitakis I, Rachner TD, Urbschat A,
Hars O, Hofbauer LC and Hadji P: Effect of aromatase inhibition on
serum levels of sclerostin and dickkopf-1, bone turnover markers
and bone mineral density in women with breast cancer. J Cancer Res
Clin Oncol. 140:1671–1680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi RY, Yang XR, Shen QJ, Yang LX, Xu Y,
Qiu SJ, Sun YF, Zhang X, Wang Z, Zhu K, et al: High expression of
Dickkopf-related protein 1 is related to lymphatic metastasis and
indicates poor prognosis in intrahepatic cholangiocarcinoma
patients after surgery. Cancer. 119:993–1003. 2013. View Article : Google Scholar
|
|
8
|
Xu W, Wang Z, Zhang W, Qian K, Li H, Kong
D, Li Y and Tang Y: Mutated K-ras activates CDK8 to stimulate the
epithelial-to-mesenchymal transition in pancreatic cancer in part
via the Wnt/β-catenin signaling pathway. Cancer Lett. 356B:613–627.
2015. View Article : Google Scholar
|
|
9
|
Tong X, Li L, Li X, Heng L, Zhong L, Su X,
Rong R, Hu S, Liu W, Jia B, et al: SOX10, a novel
HMG-box-containing tumor suppressor, inhibits growth and metastasis
of digestive cancers by suppressing the Wnt/β-catenin pathway.
Oncotarget. 5:10571–10583. 2014.PubMed/NCBI
|
|
10
|
Liu H, Yan ZQ, Li B, Yin SY, Sun Q, Kou
JJ, Ye D, Ferns K, Liu HY and Liu SL: Reduced expression of SOX7 in
ovarian cancer: A novel tumor suppressor through the Wnt/β-catenin
signaling pathway. J Ovarian Res. 7:872014. View Article : Google Scholar
|
|
11
|
Apte U, Zeng G, Thompson MD, Muller P,
Micsenyi A, Cieply B, Kaestner KH and Monga SP: beta-catenin is
critical for early postnatal liver growth. Am J Physiol
Gastrointest Liver Physiol. 292:G1578–G1585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nejak-Bowen K and Monga SP:
Wnt/beta-catenin signaling in hepatic organogenesis. Organogenesis.
4:92–99. 2008. View Article : Google Scholar
|
|
13
|
Mikheev AM, Mikheeva SA, Maxwell JP, Rivo
JV, Rostomily R, Swisshelm K and Zarbl H: Dickkopf-1 mediated tumor
suppression in human breast carcinoma cells. Breast Cancer Res
Treat. 112:263–273. 2008. View Article : Google Scholar
|
|
14
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vámosi G, Baudendistel N, von der Lieth
CW, Szalóki N, Mocsár G, Müller G, Brázda P, Waldeck W, Damjanovich
S, Langowski J, et al: Conformation of the c-Fos/c-Jun complex in
vivo: A combined FRET, FCCS, and MD-modeling study. Biophys J.
94:2859–2868. 2008. View Article : Google Scholar
|
|
16
|
González-Sancho JM, Aguilera O, García JM,
Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F and
Muñoz A: The Wnt antagonist DICKKOPF-1 gene is a downstream target
of beta-catenin/TCF and is downregulated in human colon cancer.
Oncogene. 24:1098–1103. 2005. View Article : Google Scholar
|
|
17
|
Chien AJ, Conrad WH and Moon RT: A Wnt
survival guide: From flies to human disease. J Invest Dermatol.
129:1614–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu X, Kim JE, Sun PL, Yoo SB, Kim H, Jin Y
and Chung JH: Immunohistochemical demonstration of alteration of
β-catenin during tumor metastasis by different mechanisms according
to histology in lung cancer. Exp Ther Med. 9:311–318.
2015.PubMed/NCBI
|
|
19
|
Cui J, Xi H, Cai A, Bian S, Wei B and Chen
L: Decreased expression of Sox7 correlates with the upregulation of
the Wnt/β-catenin signaling pathway and the poor survival of
gastric cancer patients. Int J Mol Med. 34:197–204. 2014.PubMed/NCBI
|
|
20
|
Silva AL, Dawson SN, Arends MJ, Guttula K,
Hall N, Cameron EA, Huang TH, Brenton JD, Tavaré S, Bienz M, et al:
Boosting Wnt activity during colorectal cancer progression through
selective hypermethylation of Wnt signaling antagonists. BMC
Cancer. 14:8912014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
22
|
Kitagawa M, Hatakeyama S, Shirane M,
Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A and
Nakayama K and Nakayama K: An F-box protein, FWD1, mediates
ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18:2401–2410.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JS, Hur MW, Lee SK, Choi WI, Kwon YG
and Yun CO: A novel sLRP6E1E2 inhibits canonical Wnt signaling,
epithelial-to-mesenchymal transition, and induces
mitochondria-dependent apoptosis in lung cancer. PLoS One.
7:e365202012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ming M, Wang S, Wu W, Senyuk V, Le Beau
MM, Nucifora G and Qian Z: Activation of Wnt/β-catenin protein
signaling induces mitochondria-mediated apoptosis in hematopoietic
progenitor cells. J Biol Chem. 287:22683–22690. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jaeger A, Baake J, Weiss DG and Kriehuber
R: Glycogen synthase kinase-3beta regulates differentiation-induced
apoptosis of human neural progenitor cells. Int J Dev Neurosci.
31:61–68. 2013. View Article : Google Scholar
|
